Market News

Earnings Triumph: Rani Therapeutics Hldgs Surpasses EPS Expectations in Q4 2023

by Ron Finklestien

Published On: March 20, 2024 9:21 pm

RANI stock - RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q4 2023

Source: iQoncept / Shutterstock

Rani Therapeutics Hldgs (NASDAQ:RANI) has just unveiled its financial results for the fourth quarter of 2023.

Rani Therapeutics Hldgs achieved earnings per share of -27 cents, surpassing the analyst prediction of -31 cents.
The company did not disclose any revenue figures for the quarter.

InvestorPlace Earnings, powered by TradeSmith’s data, delivers instant coverage of quarterly earnings reports. Key highlights like earnings per share and revenue along with comparisons to analyst forecasts are presented seamlessly. These reports are generated automatically to expedite the dissemination of up-to-date financial information. For concerns or corrections, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/rani-stock-earnings-rani-therapeutics-hldgs-for-q4-of-2023/.